Each year at the Annual OCD Conference, we recognize the many advocates, experts, and other passionate individuals who have made meaningful contributions to the OCD community over the years.
Today, we want to highlight the winners of the IOCDF Outstanding Career Achievement Award, who will be honored during the Keynote & General Session on Saturday, July 30, during the OCD Conference.
We are pleased to announce that the joint winners of the 2016 IOCDF Outstanding Career Achievement Award are José Anibal Yaryura-Tobias, MD (posthumous) & Fugen Neziroglu, PhD.
Dr. Yaryura-Tobias presented or published over 270 scientific papers and book chapters. He conducted the first double blind placebo studies in the world using clomipramine. He requested that the pharmaceutical company make this medication available in the United States because there was nothing available to patients with OCD.
Dr. Neziroglu has presented over 100 papers in scientific journals and is the author or co-author of 14 books on OCD and related disorders. She established the first outpatient intensive cognitive behavioral treatment program for the treatment of OCD in the U.S. in 1976. She is also a regular contributor to the IOCDF’s online education and newsletters as well as serving as the President of OCD New York, an affiliate of the IOCDF.